CXCR7 agonists can be alternative choices but with the diverse roles of CXCR7 have been reported, ranging from compensating for CXCR4 inhibitors, promoting cancer progression, treatment failure [34, 35], and to counteracting CXCL12 function [35, 36]. Here, ACKR3 is linked to cancer.